$0.00
1
5
$0.00
1
5
Trader mode: Actionable analysis for identifying opportunities and edge
FDA - BPC If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before X 1, Y then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion. This market will
AI-generated analysis based on market data. Not financial advice.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
5 markets tracked
No data available
| Market | Platform | Price |
|---|---|---|
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before 2027) | Kalshi | 83% |
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before November) | Kalshi | 82% |
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before September) | Kalshi | 77% |
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before July) | Kalshi | 22% |
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before May) | Kalshi | 6% |
No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/bsB1Lo" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="When will the FDA reclassify BPC-157 to Category 1?"></iframe>